Correlation Between DexCom and Edwards Lifesciences

Can any of the company-specific risk be diversified away by investing in both DexCom and Edwards Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DexCom and Edwards Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between DexCom Inc and Edwards Lifesciences, you can compare the effects of market volatilities on DexCom and Edwards Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DexCom with a short position of Edwards Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of DexCom and Edwards Lifesciences.

Diversification Opportunities for DexCom and Edwards Lifesciences

0.92

Correlation Coefficient

DexCom  Edwards Lifesciences

Almost no diversification

The 3 months correlation between DexCom and Edwards is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding DexCom Inc and Edwards Lifesciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edwards Lifesciences and DexCom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DexCom Inc are associated (or correlated) with Edwards Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edwards Lifesciences has no effect on the direction of DexCom i.e., DexCom and Edwards Lifesciences go up and down completely randomly.

Pair Corralation between DexCom and Edwards Lifesciences

Assuming the 90 days horizon DexCom Inc is expected to generate 1.38 times more return on investment than Edwards Lifesciences. However, DexCom is 1.38 times more volatile than Edwards Lifesciences. It trades about 0.14 of its potential returns per unit of risk. Edwards Lifesciences is currently generating about 0.13 per unit of risk. If you would invest  7,028  in DexCom Inc on September 23, 2024 and sell it today you would earn a total of  473.00  from holding DexCom Inc or generate 6.73% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

DexCom Inc  vs.  Edwards Lifesciences

DexCom Inc

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in DexCom Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, DexCom reported solid returns over the last few months and may actually be approaching a breakup point.

Edwards Lifesciences

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Edwards Lifesciences are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Edwards Lifesciences reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with DexCom and Edwards Lifesciences

The main advantage of trading using opposite DexCom and Edwards Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DexCom position performs unexpectedly, Edwards Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will offset losses from the drop in Edwards Lifesciences' long position.

The idea behind DexCom Inc and Edwards Lifesciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.